These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38762191)
1. SLC11A1 promotes kidney renal clear cell carcinoma (KIRC) progression by remodeling the tumor microenvironment. Wu D; Zhou Y; Shi X; Yi X; Sheng Z; Fan L; Ge J; Cheng W; Zhou W; He H; Fu D Toxicol Appl Pharmacol; 2024 Jun; 487():116975. PubMed ID: 38762191 [TBL] [Abstract][Full Text] [Related]
2. Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC. Li H; Fei M; Zhang Y; Xu Q; Feng R; Cao J; Qu Y; Xiao H Gene; 2024 Jul; 914():148403. PubMed ID: 38521112 [TBL] [Abstract][Full Text] [Related]
3. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription. Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495 [TBL] [Abstract][Full Text] [Related]
4. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma. Zou X; Mo Z Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261 [TBL] [Abstract][Full Text] [Related]
5. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma. Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412 [No Abstract] [Full Text] [Related]
6. Rho GTPase-activating protein 4 is upregulated in Kidney Renal Clear Cell Carcinoma and associated with poor prognosis and immune infiltration. Xiao X; Lv X; Lin T; Li J; Wang R; Tian S; Liu X; Liu S; Jiang H; Yue D; Wang Y Cancer Biomark; 2024; 40(2):205-223. PubMed ID: 38905034 [TBL] [Abstract][Full Text] [Related]
7. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma. Chang Y; Li N; Yuan W; Wang G; Wen J Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma. Chen C; Sheng Y Technol Cancer Res Treat; 2021; 20():15330338211036233. PubMed ID: 34346239 [TBL] [Abstract][Full Text] [Related]
9. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma. Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457 [TBL] [Abstract][Full Text] [Related]
10. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling. Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070 [TBL] [Abstract][Full Text] [Related]
11. Unravelling infiltrating T-cell heterogeneity in kidney renal clear cell carcinoma: Integrative single-cell and spatial transcriptomic profiling. Chen H; Zuo H; Huang J; Liu J; Jiang L; Jiang C; Zhang S; Hu Q; Lai H; Yin B; Yang G; Mai G; Li B; Chi H J Cell Mol Med; 2024 Jun; 28(12):e18403. PubMed ID: 39031800 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive pan-cancer analysis of ZNF337 as a potential diagnostic, immunological, and prognostic biomarker. Zhang D; Liang P; Xia B; Wu J; Hu X BMC Cancer; 2024 Aug; 24(1):987. PubMed ID: 39123194 [TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling. Ye Y; Zhang F; Chen Q; Huang Z; Li M Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578 [TBL] [Abstract][Full Text] [Related]
14. Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma. Hu Y; Gu Y; Song Y; Zhao Y; Wang J; Ma J; Sui F Mol Cell Probes; 2024 Jun; 75():101959. PubMed ID: 38579915 [TBL] [Abstract][Full Text] [Related]
15. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
16. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment. Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y Front Immunol; 2022; 13():926461. PubMed ID: 36311770 [TBL] [Abstract][Full Text] [Related]
17. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients. Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244 [TBL] [Abstract][Full Text] [Related]
18. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing. Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q Biochem Genet; 2024 Jun; 62(3):1502-1520. PubMed ID: 37642814 [TBL] [Abstract][Full Text] [Related]
19. JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma. Liang F; Liang H; Li Z; Huang P Int Immunopharmacol; 2020 Sep; 86():106706. PubMed ID: 32570038 [TBL] [Abstract][Full Text] [Related]
20. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma. Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]